Authors: Poupart, MA Cameron, DR Chabot, C Ghiro, E Goudreau, N Goulet, S Poirier, M Tsantrizos, YS

Citation: Ma. Poupart et al., Solid-phase synthesis of peptidomimetic inhibitors for the hepatitis C virus NS3 protease, J ORG CHEM, 66(14), 2001, pp. 4743-4751

Authors: Llinas-Brunet, M Bailey, M Fazal, G Ghiro, E Gorys, V Goulet, S Halmos, T Maurice, R Poirier, M Poupart, MA Rancourt, J Thibeault, D Wernic, D Lamarre, D

Citation: M. Llinas-brunet et al., Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: Towards smaller inhibitors, BIOORG MED, 10(20), 2000, pp. 2267-2270

Authors: Llinas-Brunet, M Beaulieu, PL Cameron, DR Ferland, JM Gauthier, J Ghiro, E Gillard, J Gorys, V Poirier, M Rancourt, J Wernic, D

Citation: M. Llinas-brunet et al., Phosphotyrosine-containing dipeptides as high-affinity ligands for the p56(lck) SH2 domain, J MED CHEM, 42(4), 1999, pp. 722-729

Authors: Beaulieu, PL Cameron, DR Ferland, JM Gauthier, J Ghiro, E Gillard, J Gorys, V Poirier, M Rancourt, J Wernic, D Llinas-Brunet, M Betageri, R Cardozo, M Hickey, ER Ingraham, R Jakes, S Kabcenell, A Kirrane, T Lukas, S Patel, U Proudfoot, J Sharma, R Tong, L Moss, N

Citation: Pl. Beaulieu et al., Ligands for the tyrosine kinase p56(lck) SH2 domain: Discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacements, J MED CHEM, 42(10), 1999, pp. 1757-1766